Human medicines European public assessment report (EPAR): Exjade, deferasirox, beta-Thalassemia;Iron Overload, Date of authorisation: 28/08/2006, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR): Esperoct, turoctocog alfa pegol, Hemophilia A, Date of authorisation: 20/06/2019, Revision: 6, Status: Authorised

News bulletin for small and medium-sized enterprises - Issue 60

Minutes of the CHMP meeting 11-14 September 2023

List of European Union reference dates and frequency of submission of periodic safety update reports (PSURs)

Organisation chart: Task Forces

Task Forces

New product information wording – Extracts from PRAC recommendations on signals adopted at the 23-26 October PRAC

Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 16/02/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos), daunorubicin,cytarabine, Leukemia, Myeloid, Acute, Date of authorisation: 23/08/2018, Revision: 9, Status: Authorised